Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | FADS1 | O60427 | 2/20 | 0.47 |
| ▸ | NOS2 | P35228 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GCK | P35557 | 2/20 | 0.42 |
| ▸ | ABL1 | P00519 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL523743 | 1.00 | RECQL (0.53) | RECQLFADS1NOS2ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL30522383 | 0.98 | RECQL (0.51) | RECQLFADS1NOS2ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL16992931 | 0.98 | RECQL (0.51) | RECQLFADS1NOS2ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL30522385 | 0.96 | RECQL (0.50) | RECQLFADS1NOS2ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1052365 | 0.96 | RECQL (0.50) | RECQLFADS1NOS2ALDH1A1SMN1; SMN2 | |
| SCHEMBL8087168 | 0.87 | RECQL (0.56) | RECQLFADS1NOS2ALDH1A1SMN1; SMN2 | |
| SCHEMBL25261672 | 0.83 | RECQL (0.54) | RECQLFADS1NOS2ALDH1A1SMN1; SMN2 | |
| SCHEMBL13151996 | 0.81 | RECQL (0.53) | RECQLFADS1NOS2ALDH1A1SMN1; SMN2 | |
| SCHEMBL9937692 | 0.81 | ALDH1A1 (0.59) | RECQLALDH1A1SMN1; SMN2CYP3A4TSHR | |
| SCHEMBL121698 | 0.81 | TMPRSS4 (0.44) | ALDH1A1SMN1; SMN2TSHRKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118702582-A | Preparation method of 4-chloro-2- (trifluoroacetyl) aniline hydrochloride hydrate | 浙江沙星科技股份有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-112300014-B | Method for synthesizing 4-chloro-2- (trifluoroacetyl) aniline by using microchannel reactor | 浙江江北药业有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-222641616-U | Processing apparatus of lithium chloride crystallization is precipitated in waste liquid | 黄石市博尔化工有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-118702582-A | Preparation method of 4-chloro-2- (trifluoroacetyl) aniline hydrochloride hydrate | 浙江沙星科技股份有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-114920268-B | Method for separating metal salts from mixed salts of wastewater from production of efavirenz intermediates | 盐城迪赛诺制药有限公司 | 2023-09-05 | — | — | CN | disclosed |
| US-11465958-B2 | Process for Friedel-Crafts reaction, and catalyst therefore | FUJIAN YONGJING TECHNOLOGY CO., LTD. (CN) | 2022-10-11 | — | — | US | disclosed |
| CN-112300014-B | Method for synthesizing 4-chloro-2- (trifluoroacetyl) aniline by using microchannel reactor | 浙江江北药业有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-112300014-B | Method for synthesizing 4-chloro-2- (trifluoroacetyl) aniline by using microchannel reactor | 浙江江北药业有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-112300014-B | Method for synthesizing 4-chloro-2- (trifluoroacetyl) aniline by using microchannel reactor | 浙江江北药业有限公司 | 2022-09-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11465958-B2 | Process for Friedel-Crafts reaction, and catalyst therefore | HNF4A, TFEB, HACL2 | RECQL 3975/4885FADS1 643/4885NOS2 3825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.